The novel therapy of the medication represents a exciting advance in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide363249.designi1.com/62792802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment